BasoFunction™ HRT Acetaminophen
*Build Your Own Panel Eligible [?]
|
$480
|
|
|
Description:
This test may be useful with patients for whom skin testing and/or in vitro IgE testing in not appropriate or available. This is an in vitro challenge of whole blood with histamine as a measure of cell stimulation.
Patient Instructions:
Patients taking calcineurin inhibitors should stop their medication 72 hours prior to draw. Patients taking prednisone should stop medication for 2 weeks prior to draw.
Categories:
Allergy blood testing,
Price:
$480
|
|
BasoFunction™ HRT Amoxicillin
*Build Your Own Panel Eligible [?]
|
$480
|
|
|
Description:
This test may be useful with patients for whom skin testing and/or in vitro specific IgE testing is not appropriate or available. This is an in vitro challenge of whole blood with histamine as a measure of cell stimulation.
Categories:
Price:
$480
|
|
BasoFunction™ HRT Cephalosporin
*Build Your Own Panel Eligible [?]
|
$480
|
|
|
Description:
This test may be useful with patients for whom skin testing and/or in vitro IgE testing is not appropriate or available. This is an in vitro challenge of whole blood with histamine as a measure of cell stimulation.
Alternative names: Progene® BasoFunction™ Test
Patient Instructions:
Patients taking calcineurin inhibitors should stop their medication 72 hours prior to draw.
Categories:
Allergy blood testing,
Price:
$480
|
|
BasoFunction™ HRT Ciprofloxacin
*Build Your Own Panel Eligible [?]
|
$480
|
|
|
Description:
This test may be useful with patients for whom skin testing and/or in vitro IgE testing in not appropriate or available. This is an in vitro challenge of whole blood with histamine as a measure of cell stimulation.
Categories:
Price:
$480
|
|
BasoFunction™ HRT Lys-Aspirin
*Build Your Own Panel Eligible [?]
|
$480
|
|
|
Description:
This test may be useful with patients for whom skin testing and/or in vitro specific IgE testing is not appropriate or available. This is an in vitro challenge of whole blood with histamine as a measure of cell stimulation.
Patient Instructions:
Patients taking calcineurin inhibitors should stop their medication 72 hours prior to draw.
Categories:
Allergy blood testing,
Price:
$480
|
|
BasoFunction™ HRT Monosodium Glutamate
*Build Your Own Panel Eligible [?]
|
$480
|
|
|
Description:
This test may be useful with patients for whom skin testing and/or in vitro IgE testing in not appropriate or available. This is an in vitro challenge of whole blood with histamine as a measure of cell stimulation.
Categories:
Price:
$480
|
|
BasoFunction™ HRT Penicillin (Benzylpen)
*Build Your Own Panel Eligible [?]
|
$480
|
|
|
Description:
This test may be useful with patients for whom skin testing and/or in vitro IgE testing in not appropriate or available. This is an in vitro challenge of whole blood with histamine as a measure of cell stimulation.
Categories:
Price:
$480
|
|
BasoFunction™ HRT Penicillin (Minor Det)
*Build Your Own Panel Eligible [?]
|
$480
|
|
|
Description:
This test may be useful with patients for whom skin testing and/or in vitro IgE testing in not appropriate or available. This is an in vitro challenge of whole blood with histamine as a measure of cell stimulation.
Patient Instructions:
Patients taking calcineurin inhibitors should stop their medication 72 hours prior to draw.
Categories:
Allergy blood testing,
Price:
$480
|
|
BasoFunction™ HRT Potassium Metabisulphite
*Build Your Own Panel Eligible [?]
|
$480
|
|
|
Description:
This test may be useful with patients for whom skin testing and/or in vitro IgE testing in not appropriate or available. This is an in vitro challenge of whole blood with histamine as a measure of cell stimulation.
Categories:
Price:
$480
|
|
BasoFunction™ HRT Sodium Benzoate
*Build Your Own Panel Eligible [?]
|
$480
|
|
|
Description:
This test may be useful with patients for whom skin testing and/or in vitro specific IgE testing is not appropriate or available. This is an in vitro challenge of whole blood with histamine as a measure of cell stimulation.
Categories:
Price:
$480
|
|
BasoFunction™ HRT Sodium Nitrite
*Build Your Own Panel Eligible [?]
|
$480
|
|
|
Description:
This test may be useful with patients for whom skin testing and/or in vitro IgE testing in not appropriate or available. This is an in vitro challenge of whole blood with histamine as a measure of cell stimulation.
Categories:
Price:
$480
|
|
BasoFunction™ HRT Sodium Salicylate
*Build Your Own Panel Eligible [?]
|
$480
|
|
|
Description:
This test may be useful with patients for whom skin testing and/or in vitro IgE testing in not appropriate or available. This is an in vitro challenge of whole blood with histamine as a measure of cell stimulation.
Categories:
Price:
$480
|
|
BasoFunction™ HRT Sulfamethoxazole
*Build Your Own Panel Eligible [?]
|
$480
|
|
|
Description:
This test may be useful with patients for whom skin testing and/or in vitro IgE testing in not appropriate or available. This is an in vitro challenge of whole blood with histamine as a measure of cell stimulation.
Categories:
Price:
$480
|
|
BasoFunction™ HRT Tartrazine
*Build Your Own Panel Eligible [?]
|
$480
|
|
|
Description:
This test may be useful with patients for whom skin testing and/or in vitro IgE testing in not appropriate or available. This is an in vitro challenge of whole blood with histamine as a measure of cell stimulation.
Categories:
Price:
$480
|
|
BasoFunction™ HRT Tetracycline
*Build Your Own Panel Eligible [?]
|
$480
|
|
|
Description:
This test may be useful with patients for whom skin testing and/or in vitro specific IgE testing is not appropriate or available. This is an in vitro challenge of whole blood with histamine as a measure of cell stimulation.
Categories:
Price:
$480
|
|
Bass Black (Sea Bass) (Centropristis striata) IgE
*Build Your Own Panel Eligible [?]
|
$200
|
|
|
Description:
This assay is used to detect allergen specific-IgE using an Enzyme Immunoassay (EIA). In vitro allergy testing is the primary testing mode for allergy diagnosis.
Categories:
Price:
$200
|
|
B-cell Clonality Panel (IGH, IGK), PCR
*Build Your Own Panel Eligible [?]
|
$1257
|
|
|
Description:
This assay, which interrogates the immunoglobulin kappa light chain gene (IGK) and the immunoglobulin heavy chain (IGH), by a PCR method based on the BIOMED-2 consensus, is useful for establishing clonality of B-cell lymphoid neoplasms. It can be used also for identification of minimal residual disease or early recurrence in patients with a previous diagnosis of a B-cell neoplasm. Testing for both IGH and IGK gene rearrangements is reported to detect up to 99% of B-cell malignancies, compared to 80-90% for IGH and 85-90% for IGK alone.
Categories:
Price:
$1257
|
|
B-cell Receptor IGH Gene Rearrangement, PCR
*Build Your Own Panel Eligible [?]
|
$702
|
|
|
Description:
This assay, which interrogates the immunoglobulin heavy chain gene (IGH) by a PCR method based on the BIOMED-2 consensus, is useful for establishing clonality of B-cell neoplasms and in the identification of minimal residual disease or early recurrence in patients with a previous diagnosis of a B-cell neoplasm. It can be used in association with the immunoglobulin kappa light chain (IGK test code 90363, or IDH/IGK combo test code 91635), since false-negative results can occur in up to 10-20% of B-cell malignancies when testing for IGH only. The highest rates of non-detectable IGH clonal rearrangements are in IGV- mutated B-cell neoplasms such as follicular lymphoma and plasma cell neoplasms and in B-lymphoblastic leukemia/lymphoma due to absent or incomplete B-cell receptor rearrangements.
Categories:
Price:
$702
|
|
B-cell Receptor IGK Gene Rearrangement, PCR
*Build Your Own Panel Eligible [?]
|
$702
|
|
|
Description:
This assay, which interrogates the immunoglobulin kappa light chain gene (IGK) by a PCR method based on the BIOMED-2 consensus, is useful for establishing clonality of B-cell lymphoid neoplasms and in the identification of minimal residual disease or early recurrence in patients with a previous diagnosis of B-cell neoplasm. It can be used in association with the immunoglobulin heavy chain (IGH PCR assay test code 90362), since false-negative results can occur in up to 10-25% of B-cell malignancies with testing IGK only.
Categories:
Price:
$702
|
|
bcl-2, IHC with Interpretation
*Build Your Own Panel Eligible [?]
|
$281
|
|
|
Description:
To help with the diagnosis of lymphomas of follicular cell origin, in paraffin embedded tissues. About 90% of follicular lymphomas have a translocation that juxtaposes the bcl-2 gene to an immunoglobulin gene with subsequent deregulation of protein synthesis and cell proliferation.
Categories:
Price:
$281
|
|
bcl-6, IHC with Interpretation
*Build Your Own Panel Eligible [?]
|
$442
|
|
|
Description:
The following CD markers are expressed on specific hematologic cells. Individual and a series of IHC markers can be run on unknown cells and presence or absence of the antigen can help to characterize the cell of interest.
Categories:
Price:
$442
|
|
BCR-ABL1 Gene Rearrangement, Quantitative, PCR
*Build Your Own Panel Eligible [?]
|
$618
|
|
|
Description:
The Philadelphia Chromosome (Ph) is a translocation between chromosome 9 and 22 t(9; 22) (q34; Q11) that is found in more than 90-95% of chronic myeloid leukemia (CML), and in 20-25% of adult and 2-10% of childhood acute lymphoblastic leukemia (ALL). In CML, most translocations fall in the major breakpoint cluster region of the BCR gene, and result in either of two BCR-ABL1 mRNA molecules having an e13a2 junction (fusion of BCR exon 13 with ABL1 exon 2) or an e14a2 junction (fusion of BCR exon 14 with ABL1 exon 2) that encodes the p210 BCR-ABL1 fusion protein. In all, about two thirds of the BCR breakpoints fall in the minor breakpoint cluster region of the BCR gene, and the hybrid BCR-ABL1 transcript contains an e1a2 junction (fusion of BCR exon1 with AB11 exon2) which is translated as a p190 BCR-ABL1 fusion protein. Quantitative measurement of the changes of BCR-AB1 expression levels over time is important to monitor disease progression and response to targeted therapies. This test is a reverse-transcription pcr-based quantitative assay which detects these two major BCR-AB11 mRNA transcripts produced by the t(9; 22) chromosomal translocation (p210 and p190). BCR-ABL1 transcript levels are expressed as a percent ratio of BCR-ABL1 to the normalizing ABL1 transcript levels. For the p210 transcript associated with CML, quantitation is further adjusted to the international scale (IS) to allow comparison with other IS-compliant BCR-ABL1 assays. Optimal therapy in CML is associated with transcript levels below the major molecular response (MMR) milestone indicated by a BCR-ABL1/ABL1% (is) below 0.1.
Categories:
Price:
$618
|
|
Beech (t5) IgE
*Build Your Own Panel Eligible [?]
|
$49
|
|
|
Description:
This test quantifies an individual's IgE response to beech. Allergen-specific serum IgE testing is considered comparable to skin testing and may be preferred in some clinical situations. However, a positive test result only indicates that a patient is sensitized to the allergen of concern. Many IgE-sensitized individuals do not develop any symptoms when exposed to the allergen. A diagnosis of allergy should only be made by a trained medical provider after conducting a thorough clinical evaluation [1].More specific information about this allergen can be found on the following website: https://www.thermofisher.com/phadia/us/en/resources/allergen-encyclopedia.htmlReference 1. Bernstein IL, et al. Ann Allergy Asthma Immunol. 2008;100(3 Suppl 3):S1-S148.
Categories:
Price:
$49
|
|
Beef (f27) IgE
*Build Your Own Panel Eligible [?]
|
$49
|
|
|
Description:
This test detects the presence of specific IgE against beef. A positive test only indicates that a person is sensitized and potentially allergic to this allergen. A diagnosis of allergy requires clinical signs and symptoms that appear to be associated with exposure to the allergen in addition to the detection of markers of IgE sensitization [1].More specific information about this allergen can be found on the following website: https://www.thermofisher.com/phadia/us/en/resources/allergen-encyclopedia.htmlReference1. Bernstein IL, et al. Ann Allergy Asthma Immunol. 2008;100(3 Suppl 3):S1-S148.
Categories:
Price:
$49
|
|
Beef (f27) IgG
*Build Your Own Panel Eligible [?]
|
$118
|
|
Description:
- Check beef food sensitivity reactions
- Identify digestive discomfort triggers today
- Screen for hidden dietary immune responses
Categories:
Price:
$118
|
|
Beetroot (Beta vulgaris) (f319) IgE
*Build Your Own Panel Eligible [?]
|
$49
|
|
|
Description:
This test detects the presence of specific IgE against beetroot. A positive test only indicates that a person is sensitized and potentially allergic to this allergen. A diagnosis of allergy requires clinical signs and symptoms that appear to be associated with exposure to the allergen in addition to the detection of markers of IgE sensitization [1].More specific information about this allergen can be found on the following website: https://www.thermofisher.com/phadia/us/en/resources/allergen-encyclopedia.htmlReference1. Bernstein IL, et al. Ann Allergy Asthma Immunol. 2008;100(3 Suppl 3):S1-S148.
Categories:
Price:
$49
|
|
Benzene, Blood
*Build Your Own Panel Eligible [?]
|
$306
|
|
Description:
- Check benzene chemical exposure levels
- Screen for workplace fuel exposure
- Monitor ongoing solvent exposure risks
Categories:
Price:
$306
|
|
Benzene Incident, Urine (OSHA)
*Build Your Own Panel Eligible [?]
|
$374
|
|
|
Description:
Occupational exposure incident. Expedited reporting based on OSHA required guidelines.
Includes:
Specific Gravity
Phenol Total
Phenol Total (Specific Gravity corrected)
Categories:
Allergy blood testing,
Geriatrics/Age Management,
Neurology,
Pediatrics,
Price:
$374
|
|
Benzodiazepine, Confirmation, Urine
*Build Your Own Panel Eligible [?]
|
$319
|
|
Description:
- Confirm benzodiazepine presence in urine
- Verify prescription medication compliance easily
- Detect unexpected substance use privately
Categories:
Price:
$319
|
|
Benzodiazepines, Serum
*Build Your Own Panel Eligible [?]
|
$333
|
|
|
Description:
Benzodiazepines are widely used as anxiolytics, sedative- hypnotics, muscle relaxants, and anticonvulsants. Benzodiazepines include drugs such as diazepam Valium®, chlordiazepoxide Librium®, oxazepam Serax®, lorazepam Ativan®, alprazolam Xanax®, clonazepam Clonopin® and triazolam Halcion®. Many common benzodiazepines are detected in urine by their metabolites oxazepam and nordiazepam. Psychological and physiological addictions, misuse and abuse of benzodiazepines have been described.
Categories:
Price:
$333
|
|
Benztropine, Serum/Plasma
*Build Your Own Panel Eligible [?]
|
$326
|
|
|
Description:
Therapeutic drug monitoring.
Categories:
Price:
$326
|
|
Bermuda Grass (g2) IgE
*Build Your Own Panel Eligible [?]
|
$80
|
|
|
Description:
Alternative names: ImmunoCAP®
Categories:
Allergy blood testing,
Price:
$80
|
|
Beryllium, Blood
*Build Your Own Panel Eligible [?]
|
$306
|
|
|
Description:
Exposure monitoring/investigation
Categories:
Price:
$306
|
|
Beryllium, Serum/Plasma
*Build Your Own Panel Eligible [?]
|
$306
|
|
|
Description:
Exposure monitoring/investigation.
Categories:
Price:
$306
|
|
Beryllium, Urine
*Build Your Own Panel Eligible [?]
|
$363
|
|
|
Description:
Beryllium is used as a neutron modulator in nuclear reactors and inertial systems. It can also be found in the manufacturing of electronic and radio tubes, electric heating elements and x-ray tube windows. Beryllium is a component of radar devices, nose cones, jet plane brakes and missiles. It is highly toxic with death resulting from very short exposure to low concentrations of the element or its salts. Symptoms include dermatitis, corneal burns, non-healing ulcerations, vomiting, cyanosis and nausea.
Categories:
Price:
$363
|
|
Beta-2-Adrenergic Receptor Mutations
*Build Your Own Panel Eligible [?]
|
$681
|
|
|
Description:
This test detects two polymorphisms in the beta-2 adrenergic receptor (ADRB2) gene: Gly16Arg and Gln27Glu, which have been shown to correlate with the phenotype of bronchodilator responsiveness in asthma.
Categories:
Price:
$681
|
|
Beta-2-Glycoprotein I Antibodies (IgG, IgA, IgM)
*Build Your Own Panel Eligible [?]
|
$618
|
|
|
Description:
Beta-2-Glycoprotein 1 (also known as apolipoprotein H), is a cofactor in antiphospholipid antibody binding and is the critical antigen in the antiphospholipid antibody syndrome. The presence of high titer IgG/IgM beta-2-glycoprotein 1 antibodies is one criteria for the diagnosis of antiphospholipid antibody syndrome.
Categories:
Price:
$618
|
|
Beta-2-Glycoprotein I Antibody (IgA)
*Build Your Own Panel Eligible [?]
|
$325
|
|
|
Description:
Beta-2-Glycoprotein 1, apolipoprotein H, is a cofactor in antiphospholipid antibody binding and is the critical antigen in the antiphospholipid antibody syndrome. Beta-2- Glycoprotein 1 antibody is more specific than cardiolipin antibody that may express reactivity in patients with syphilis and other infectious diseases.
Categories:
Price:
$325
|
|
Beta-2-Glycoprotein I Antibody (IgG)
*Build Your Own Panel Eligible [?]
|
$293
|
|
|
Description:
Beta-2-Glycoprotein 1, apolipoprotein H, is a cofactor in antiphospholipid antibody binding and is the critical antigen in the antiphospholipid antibody syndrome. Beta-2- Glycoprotein 1 antibody is more specific than cardiolipin antibody that may express reactivity in patients with syphilis and other infectious diseases.
Categories:
Price:
$293
|
|
Beta-2-Glycoprotein I Antibody (IgG) with Reflex to B2GPI-Domain 1
*Build Your Own Panel Eligible [?]
|
$293
|
|
|
Description:
The antiphospholipid syndrome (APS) is a systemic autoimmune disorder characterized venous and/or arterial thrombosis (intravascular blood clotting), thrombocytopenia, recurrent fetal loss, and moderate-to-high titers of antiphospholipid (aPL) antibodies, lupus anticoagulant (LA), anti-cardiolipin (aCL) antibodies and anti-Beta-2-glycoprotein I (aB2GPI) antibodies.aPL antibodies are autoantibodies that react with negatively charged phospholipids (e.g. Cardiolipin). They are frequently found in sera of patients with systemic lupus erythematosus (SLE) and related diseases and are typical for the development of secondary APS. The presence of antiphospholipid antibodies in patients with no other autoimmune diseases is characteristic of primary APS. Because aCL antibodies are found in 80-90% of patients with APS, this test is very sensitive for the diagnosis of the syndrome. However, the aCL test is not specific to APS because aCL antibodies can also be detected in other autoimmune diseases, following administration of several drugs, and in the aftermath of infectious diseases (e.g., syphilis, hepatitis C and infectious mononucleosis).B2GPI, also known as apolipoprotein H, is a 54 kDa serum cofactor (protein) that inhibits the intrinsic coagulation pathway and is involved in the regulation of blood coagulation. Detailed investigations about the nature of the cardiolipin-B2GPI complex have shown that B2GPI is the real autoantigen of anti-cardiolipin antibodies. In addition to being a prerequisite for binding to anti-cardiolipin antibodies, B2GPI has been identified as the primary antigen for these antibodies. Hence, an assay with a B2GPI bound solid phase will not bind antibodies from other disease states, e.g., in syphilis positive samples, and will show better overall disease specificity.A definite diagnosis of APS requires the presence of at least one clinical manifestation and one positive laboratory test result. The clinical criteria include thrombosis and one of the following three during pregnancy: one or more pregnancy losses after the 10th gestational week; one or more episodes of pre-term delivery before the 34th gestational week due to severe pre-eclampsia or severe placental insufficiency; or three or more recurrent pregnancy losses before the 10th gestational week. The laboratory criteria include the detection of IgG aCL or aB2GPI antibodies in moderate to high titers, in two different measurements at least 12 weeks apart; or detection of LA in two different measurements at least 12 weeks apart.Anti-B2GPI antibodies have been reported to bind to epitopes located primarily on domains 1, 4, and 5 of the B2GPI molecule. Importantly, the main B2GPI epitope specifically associated with antiphospholipid syndrome has been reported to be a cryptic and conformation dependent structure that involves different regions of domain 1. If testing is positive for aB2GPI IgG antibodies, reflex testing will be performed to determine if the antibodies are directed to B2GPI domain 1. A positive B2GPI domain 1, IgG antibody test result may be useful in identifying patients at increased risk for arterial and venous thrombosis and pregnancy morbidity.
Categories:
Price:
$293
|
|
Beta-2-Glycoprotein I-Domain 1 Antibody (IgG)
*Build Your Own Panel Eligible [?]
|
$293
|
|
|
Description:
Antiphospholipid syndrome (APS) is a systemic autoimmune disorder, characterized by recurrent arterial or venous thrombosis, and/or early and late miscarriages. Autoantibodies to phospholipids and to beta-2-glycoprotein 1 (B2GP1) play an important role in the pathogenesis of APS, and the measurement of these antibodies aids the diagnosis and management of the syndrome. Beta-2-glycoprotein 1, also called apolipoprotein H, is a 54 kDa glycoprotein with five domains that is present in plasma. The fifth domain contains a cluster of positively charged amino acids which is responsible for the binding to anionic phospholipids. APS patients can produce antibodies against several epitopes of the molecule. Antibodies to B2GPI are directed to one of the five domains of B2GPI, but only IgG antibodies directed to epitopes on one domain (called Domain 1 or D1) have been shown to be associated with increased risk of venous thrombosis. Even greater risk of venous thrombosis has been shown when phosphatidylserine/prothrombin antibodies are also present. This test should be used when B2GP1 IgG antibodies are present to determine whether the antibodies are directed to Domain 1. The presence of B2GPI Domain 1 antibodies should be confirmed by repeat testing at least 12 weeks apart.
Categories:
Price:
$293
|
|
Beta-2-Microglobulin, Random Urine with Creatinine
*Build Your Own Panel Eligible [?]
|
$419
|
|
|
Description:
Beta-2 Microglobulin (B2M) is a low molecular weight protein that forms the light chain component of the histocompatibility antigen. It is synthesized by all nucleated cell types. It is an integral part of the class I MHC antigens and is present in all body fluids. B2M is filtered through the glomeruli of the kidney and is then reabsorbed and catabolized by the proximal tubular cells. In normal patients only trace amounts of B2M appear in the urine. Elevated urine B2M is seen in tubulo-interstitial disorders. Increased urine B2M is seen in cadmium exposure, diatrizoate, exercise, fever, nephrectomy, semen. There is evidence that monitoring B2M levels in HIV-infected individuals offers an independent predictor of progression to AIDS, leukemia and lymphoma.
Categories:
Price:
$419
|
|
Beta-2 Microglobulin, Serum
*Build Your Own Panel Eligible [?]
|
$119
|
|
|
Description:
Beta-2-microglobulin normally passes through the glomerulus into the proximal tubule where much of it is reabsorbed. Serum levels are therefore an index of glomerular function. When impaired, serum levels rise in inverse ratio to glomerular filtration rate. Increased amounts of beta-2-microglobulin are excreted in several renal disorders, e.g., Balkan nephropathy, heavy metal poisoning and renal tubular disease due to therapeutic agents. Serial levels of beta-2-microglobulin in serum and urine are used to evaluate transplant viability and anticipate rejection. Following a successful graft, serum levels decline toward normal. Increasing serum levels provide an early sign of rejection. Elevated levels are also noted in lymphproliferative disorders, neoplasms (malignant and benign), inflammatory disease, and autoimmune diseases such as systemic lupus erythematosus (SLE) and Sjögren's disease.
A significant deviation from the normal range may require further evaluation by your physician.
Includes:
Beta-2 Microglobulin, Serum.
Estimated turnaround for results is 4 business days.
Categories:
Kidney diseases,
Price:
$119
|
|
Beta-2-Microglobulin, Urine
*Build Your Own Panel Eligible [?]
|
$358
|
|
|
Description:
Beta-2-Microglobulin (B2M) is a low molecular weight protein that forms the light chain component of the histocompatibility antigen. It is synthesized by all nucleated cell types. It is an integral part of the class I MHC antigens and is present in all body fluids. B2M is filtered through the glomeruli of the kidney and is then reabsorbed and catabolised by the proximal tubular cells. In normal patients only trace amounts of B2M appear in the urine. Elevated urine B2M is seen in tubulo-interstitial disorders. Increased urine B2M is seen in cadmium exposure, diatrizoate, exercise, fever, nephrectomy, semen. There is evidence that monitoring B2M levels in HIV-infected individuals offers an independent predictor of progression to AIDS, leukemia and lymphoma.
Categories:
Price:
$358
|
|
Beta-fibrinogen-455G→A Mutation
*Build Your Own Panel Eligible [?]
|
$681
|
|
|
Description:
This test detects a polymorphism in the promoter region of the fibrinogen gene, -455G→A, which is associated with elevated plasma fibrinogen level, an independent predictor of coronary heart disease.
Categories:
Price:
$681
|
|
Beta-Globin Complete™
*Build Your Own Panel Eligible [?]
|
$1393
|
|
|
Description:
1) To identify disease-causing mutations in individuals affected with beta-thalassemia. 2) To identify carriers in high-risk ethnic group or people with positive family history. 3) Prenatal diagnosis of beta-thalassemia.
Categories:
Price:
$1393
|
|
Beta-Globin Complete™, Fetus
*Build Your Own Panel Eligible [?]
|
$1393
|
|
|
Description:
Prenatal diagnosis of beta-thalassemia.
Categories:
Price:
$1393
|
|
Beta Globin Gene Dosage Analysis
*Build Your Own Panel Eligible [?]
|
$1174
|
|
|
Description:
Beta globin gene dosage analysis complements the sequencing-based beta globin mutation detection test in molecular diagnosis of Beta Thalassemia. It detects large deletions/duplications involving the beta globin gene.
Categories:
Price:
$1174
|
|
Beta-Hydroxybutyrate
*Build Your Own Panel Eligible [?]
|
$293
|
|
|
Description:
In diabetics, the measurement of B-hydroxybutyrate as well as blood glucose is needed for the assessment of the severity of diabetic coma and is essential for the exclusion of hyperosmolar non-ketotic diabetic coma. A specific enzymatic assay for Beta-hydroxybutyrate is extremely important in the assessment of ketosis.
Categories:
Price:
$293
|
|
Beta-Lactoglobulin (f77) IgE
*Build Your Own Panel Eligible [?]
|
$58
|
|
|
Description:
This test is an allergen-specific IgE antibody test that quantifies an individual’s IgE response to beta-lactoglobulin. It is an in vitro quantitative assay, which is intended to be used in conjunction with other clinical information to aid in the diagnosis of food allergy [1]. While allergen-specific serum IgE testing is considered comparable to skin testing in many instances, both the American Academy of Allergy, Asthma, and Immunology and the American College of Allergy, Asthma, and Immunology recognize that allergen-specific serum IgE testing may be preferred in some clinical situations. These include 1) the presence of widespread skin disease, 2) the recent use of antihistamines or other medications that can affect the results of allergy skin tests, 3) uncooperative patients, and 4) medical history suggesting that allergen skin testing would pose a significant risk for a serious allergic reaction [1]. Food-specific IgE tests are extremely sensitive. However, a positive test result only indicates that a patient is IgE sensitized to the food of concern. Many IgE-sensitized patients do not develop any symptoms when this food is ingested. A diagnosis of food allergy should only be made by a trained medical provider, after conducting a thorough clinical evaluation [2,3]. While food-specific IgE test results may contribute to that evaluation, they cannot replace it. In this regard, detection of food-specific IgE in serum provides evidence of IgE sensitization, but a history of clinical reactivity to the food of concern, is required to make a diagnosis of IgE-mediated food allergy. Moreover, several forms of food hypersensitivity are not associated with the presence of food-specific IgE in serum. More specific information about this allergen can be found at http://www.phadia.com/en/Products/Allergy-testing-products/ImmunoCAP-Allergen-Information/Food-of-Animal-Origin/Allergen-Components/nBos-d-5--lactoglobulin-Milk/ References 1. Bernstein IL, et al. Ann Allergy Asthma Immunol. 2008;100(suppl 3):S1-S148. 2. Sampson HA, et al. J Allergy Clin Immunol. 2014;134(5):1016-1025. 3. Boyce JA, et al. J Allergy Clin Immunol. 2010;126(6 suppl):S1-S58.
Categories:
Price:
$58
|
